FedSift

Agencies › Department of Health and Human Services › NAICS 325413

Department of Health and Human Services (HHS): NAICS 325413 — In-Vitro Diagnostic Substance Manufacturing

0open solicitations
$11.9Mobligated in FY2026
70contracts ending within 18 months

Open solicitations

Nothing is open in this category right now.

How HHS NAICS 325413 spends

FY2021$30.4M
FY2022$78.8M
FY2023$560.7M
FY2024$48.7M
FY2025$22.9M
FY2026$11.9M
FY2027*$84K
Contract obligations by federal fiscal year (October–September), from USASpending.gov award data. IDIQ ceilings are excluded. * The current year is partial, and USASpending lags 4–8 weeks.

HHS NAICS 325413 contracts expiring in the next 18 months

70 contracts worth $47.0M.

IncumbentBuyerWhatValueEndsEst. solicitationRecord
OXFORD NANOPORE TECHNOLOGIES, INC.NIH325413 In-Vitro Diagnostic Substance Manufacturing$253K10 October 2026Now / imminentUSASpending
ATLANTIC TRADING LLCOffice of Assistant Secretary for Preparedness and Response325413 In-Vitro Diagnostic Substance Manufacturing$26.5M29 October 2026Now / imminentUSASpending
BECTON, DICKINSON AND COMPANYNIH325413 In-Vitro Diagnostic Substance Manufacturing$119K31 October 2026Now / imminentUSASpending
CERUS CORPORATIONNIH325413 In-Vitro Diagnostic Substance Manufacturing$225K08 November 2026Now / imminentUSASpending
BECTON, DICKINSON AND COMPANYIHS325413 In-Vitro Diagnostic Substance Manufacturing$102K30 November 2026Now / imminentUSASpending
10X GENOMICS, INC.NIH325413 In-Vitro Diagnostic Substance Manufacturing$37K08 December 2026Now / imminentUSASpending
QIAGEN, LLCNIH325413 In-Vitro Diagnostic Substance Manufacturing$44K (2 orders)14 December 2026Now / imminentUSASpending
RED HERITAGE MEDICAL DIAGNOSTICS COMPANY LLCIHS325413 In-Vitro Diagnostic Substance Manufacturing$49K31 December 2026Now / imminentUSASpending
CEPHEIDIHS325413 In-Vitro Diagnostic Substance Manufacturing$41K31 December 2026Now / imminentUSASpending
CEPHEIDIHS325413 In-Vitro Diagnostic Substance Manufacturing$460K11 January 2027Now / imminentUSASpending
HARDY DIAGNOSTICSIHS325413 In-Vitro Diagnostic Substance Manufacturing$37K22 January 2027Now / imminentUSASpending
WERFEN USA LLCIHS325413 In-Vitro Diagnostic Substance Manufacturing$224K31 January 2027Now / imminentUSASpending
WERFEN USA LLCNIH325413 In-Vitro Diagnostic Substance Manufacturing$170K31 January 2027Now / imminentUSASpending
10X GENOMICS, INC.NIH325413 In-Vitro Diagnostic Substance Manufacturing$71K (3 orders)31 January 2027Now / imminentUSASpending
CEPHEIDIHS325413 In-Vitro Diagnostic Substance Manufacturing$32K31 January 2027Now / imminentUSASpending

Contracts and task orders from USASpending.gov (FPDS) whose period of performance ends within 18 months, valued at $25K or more, excluding IDIQ ceilings and government-owned, contractor-operated facility contracts. Co-terminous orders from the same vendor, agency, NAICS and PSC ending in the same month are grouped. The solicitation date is an estimate (about six months before the contract ends): FedSift does not know whether a follow-on has been posted, so check SAM.gov.

NAICS 325413 across every agency → · Everything HHS has open →